Aptorum Group (Aptorum Group) EV-to-EBIT : -2.58 (As of May. 21, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Aptorum Group's Enterprise Value is $27.70 Mil. Aptorum Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-10.72 Mil. Therefore, Aptorum Group's EV-to-EBIT for today is -2.58.

The historical rank and industry rank for Aptorum Group's EV-to-EBIT or its related term are showing as below:

APM' s EV-to-EBIT Range Over the Past 10 Years
Min: -84.1 Med: -1.59 Max: 17.39
Current: -2.58

During the past 7 years, the highest EV-to-EBIT of Aptorum Group was 17.39. The lowest was -84.10. And the median was -1.59.

APM's EV-to-EBIT is ranked worse than
100% of 427 companies
in the Biotechnology industry
Industry Median: 10.09 vs APM: -2.58

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Aptorum Group's Enterprise Value for the quarter that ended in Dec. 2023 was $4.50 Mil. Aptorum Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-10.72 Mil. Aptorum Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -238.16%.

Aptorum Group EV-to-EBIT Historical Data

The historical data trend for Aptorum Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group EV-to-EBIT Chart

Aptorum Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-27.95

9.91

-2.04

-0.95

-0.42

Aptorum Group Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial								-2.04	-	-0.95	-	-0.42

Competitive Comparison of Aptorum Group's EV-to-EBIT

For the Biotechnology subindustry, Aptorum Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptorum Group's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptorum Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Aptorum Group's EV-to-EBIT falls into.

Aptorum Group EV-to-EBIT Calculation

Aptorum Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	27.703	/	-10.724
	=	-2.58

Aptorum Group's current Enterprise Value is $27.70 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aptorum Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-10.72 Mil.

Aptorum Group (NAS:APM) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Aptorum Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-10.724	/	4.50291062
	=	-238.16 %

Aptorum Group's Enterprise Value for the quarter that ended in Dec. 2023 was $4.50 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aptorum Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-10.72 Mil.

Aptorum Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Aptorum Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptorum Group (Aptorum Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

17 Hanover Square, London, GBR, W1S 1BN

Website

https://www.aptorumgroup.com

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.